GL1X · GenesisL1 explorer

Research workbench

Vaccinia methyltransferase VP39 complexed with M7G capped RNA hexamer and S-adenosylhomocysteine

Analyse Vaccinia methyltransferase VP39 complexed with M7G capped RNA hexamer and… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1AV6
Type
protein + RNA
Length
295 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA (5'-R(*GP*AP*AP*AP*AP*A)-3'); Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase
EC
2.1.1.57
UniProt
P07617
Ligands
MGT, SAH
Pockets
4 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BRNA (5'-R(*GP*AP*AP*AP*AP*A)-3')rna6——
ACap-specific mRNA (nucleoside-2'-O-)-methyltransferase (EC 2.1.1.57)protein28940% helix, 18% strandP07617

Ligands and binding sites

  • MGT · 7N-methyl-8-hydroguanosine-5'-triphosphate · ligand · chains B, A
  • SAH · S-adenosyl-L-homocysteine · ligand · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12220.540.7835MGT
21030.500.8227SAH
31070.490.8119empty
4680.370.7713empty

Interfaces

1 interface between chains.

  • B–A · 415 Ų buried · 11 hydrogen bonds · protein-nucleic

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 1AV6 · Vaccinia methyltransferase VP39 complexed with M7G capped RNA hexamer and… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.